Hide Board Information

Show Board Information

Zhangmen Education Inc. ZMENY

Board Mod: Add me as mod

Asst Mods:

Last Post: 03/22/2022 5:11:07 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Zhangmen Education Inc. (OTCMRKTS: ZMENY) Stock Message Board

1. ZMENY Company Profile

    

2. ZMENY Time & Sales

    

3. ZMENY Recent News

    

4. ZMENY Filings

    

5. ZMENY Financials

    

6. ZMENY Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7	ZME 36% v27,3M c1.45 f19,7M H2.03	znewcar1	03/22/2022 5:11:07 PM
6	Yet recent vol and NYSE $1 limit push back. Where	znewcar1	11/22/2021 2:12:01 AM
5	$ZME keeps closing lower and	Chasing Stars	11/21/2021 7:14:09 PM
4	Looks like ZME got a break check @$1.40 with a	znewcar1	11/20/2021 12:15:01 AM
3	A lot of people didn't like my $ZME video.	Chasing Stars	11/19/2021 8:57:40 PM
2	ZME 38% v15,4M c2.09 f157M H2.23 Haft2.26 (1)	znewcar1	11/17/2021 10:22:07 PM
1	ZME Stock Chart Video Analysis 11-17-2021 (1)	Chasing Stars	11/17/2021 7:03:38 PM

Recent Articles

• PDD Holdings Prepares to Reveal Q4 and Annual Results
• MeiraGTx Speeding Phase 3 Development with Hologen AI Partnership
• Michael Herde Joins FTI Consulting to Transform Financial Services
• Trinity Biotech Expands Strategic Focus on CGM Technology
• Dragonfly Energy Unveils Upcoming Q4 2024 Financial Results
• MIRA Pharmaceuticals Unveils New Topical Treatment for Pain Relief
• PDD Holdings Set to Announce Fourth Quarter Financial Results
• FTI Consulting Welcomes New Senior Managing Director
• Verde Resources Revolutionizes Road Construction with Tech
• Altisource Reports Impressive Fourth Quarter and Yearly Gains
• Quoin Pharmaceuticals Achieves Key Milestones While Reporting 2024 Results
• Advanced Flower Capital Inc. Reveals 2024 Year-End Financials
• Tourmaline Bio Unveils Promising Financial Results and Highlights
• Understanding Alliance Witan PLC’s Net Asset Value Adjustments
• Indaptus Therapeutics: Significant Milestones and Future Prospects
• Ballard Power Systems Reports Challenging Q4 Results
• AMSURG's New Values Enhance Patient-Centric Culture
• Altisource Surpasses Revenue Expectations in 2024
• Gentoo Media Shareholders Decide on Euronext Delisting Move
• Danaos Corporation's 2024 Annual Report Now Available for Review
• Advanced Flower Capital Reports 2024 Year-End Financials
• India Giving Day: A Call to Action for Philanthropy Growth
• Virax Biolabs Unveils Findings on T-Cell Dysfunction at Conference
• Phoenix Financial Reports Strong 2024 Financial Results
• Stratus Building Solutions: Celebrating Franchise Growth Success
• DocuSign Sees Positive Analyst Ratings Ahead of Q4 Results
• Transform Your Photos with Mango AI's Innovative Tool
• The Cigna Group's Strategic Leadership Changes for Growth
• Ballard Power Systems' Q4 2024 Financial Overview and Outlook
• PSP Investments Expands Portfolio with 407 ETR Acquisition
• Dalai Lama Receives Gold Mercury Award for Peace Initiatives
• LEAD3R Introduces Innovative Workshop for Inclusive Leadership
• Phoenix Financial Unveils Strong Performance and Growth Plans
• Lucid Diagnostics Achieves Milestone with Insurance Coverage
• Onity Group's Upcoming Presentation at Major Investor Conference
• Team, Inc. Secures New Financing to Enhance Financial Stability
• Nvidia's Stock Valuation During 2025 Correction Explained
• Understanding the Impact of US Inflation Slowdown on Rates
• Intuitive Machines Stock Performance Comparison to Bitcoin
• Top Analysts Highlight 3 Dividend-Paying Materials Stocks
• Thompson Thrift Secures Over $255 Million in New Funding
• Innovative Insights into IT Security and Data Protection
• VersaBank Gears Up for Key Networking Opportunity at Conference
• Corero Network Security Pioneers AI Integration for DDoS Defense
• Arianne Phosphate Welcomes Pierre Fitzgibbon as Key Advisor
• Boss Energy Expands Its Holdings Through Strategic Acquisition
• Cartesian Therapeutics Completes 2024 Financial Review
• GD Culture Group Limited Secures Funding Through Private Placement
• Akebia Therapeutics Shows Promising Growth with Vafseo Launch
• The Surge of 3D Bioprinting: Market Trends and Predictions